Ventral hippocampal ibotenic acid lesions block chronic nicotine- induced spatial working memory improvement in rats

Cognitive Brain Research

Volumn 7, Issue 3, 1999, Pages 405-410

  Levin, Edward D ^a,b   Christopher, N Channelle ^a   Weaver, Tiffani ^a   Moore, John ^a   Brucato, Frederic ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Hippocampus; Memory; Nicotine; Radial arm maze

Indexed keywords

IBOTENIC ACID; MECAMYLAMINE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FORNIX; BRAIN INJURY; CONTROLLED STUDY; FEMALE; FIMBRIA; HIPPOCAMPUS; MAZE TEST; NEUROPATHOLOGY; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; CONDITIONING (PSYCHOLOGY); DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; FEMALE; HIPPOCAMPUS; IBOTENIC ACID; MAZE LEARNING; MEMORY, SHORT-TERM; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 0032931924     PISSN: 09266410     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-6410(98)00044-5     Document Type: Article

References (32)

1. Albuquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. Journal of Pharmacology and Experimental Therapeutics. 280:1997;1117-1136.
2. Arendash G.W., Sengstock G.J., Sanberg P.R., Kem W.R. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res. 674:1995;252-259.
3. Buccafusco J.J., Prendergast M.A., Terry A.V., Jackson W.J. Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates. Drug Dev. Res. 38:1996;196-203.
4. Decker M.W., Majchrzak M.J., Anderson D.J. Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res. 572:1992;281-285.
5. Felix R., Levin E.D. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience. 81:1997;1009-1017.
6. 3H ]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal J. Neurochem. 47:1986;1948-1954.
7. Jones G.M.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology. 108:1992;485-494.
8. Kellar K.J., Whitehouse P.J., Martino-Barrows A.M., Marcus K., Price D.L. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease. Brain Res. 436:1987;62-68.
9. Kim J., Levin E. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Brain Res. 725:1996;231-240.
10. Levin E., Kim P., Meray R. Chronic nicotine effects on working and reference memory in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs. Psychopharmacology. 127:1996;25-30.
11. Levin E.D. Nicotinic agonist and antagonist effects on memory. Drug Dev. Res. 38:1996;188-195.
12. Levin E.D., Briggs S.J., Christopher N.C., Rose J.E. Persistence of chronic nicotine-induced cognitive facilitation. Behav. Neural. Biol. 58:1992;152-158.
13. Levin E.D., Briggs S.J., Christopher N.C., Rose J.E. Chronic nicotinic stimulation and blockade effects on working memory. Behav. Pharmacol. 4:1993;179-182.
14. Levin E.D., Christopher N.C., Briggs S.J., Auman J.T. Chronic nicotinic and dopaminergic effects on spatial working memory performance in rats. Drug Dev. Res. 39:1996;29-35.
15. Levin E.D., Christopher N.C., Briggs S.J., Rose J.E. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cog. Brain Res. 1:1993;137-143.
16. Levin E.D., Lee C., Rose J.E., Reyes A., Ellison G., Jarvik M., Gritz E. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav. Neural. Biol. 53:1990;269-276.
17. Levin E.D., Rose J.E. Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. Behav. Pharmacol. 1:1990;511-520.
18. E.D. Levin, J.E. Rose, Acute and chronic nicotinic interactions with dopamine systems and working memory performance, in: A. Lajtha, L. Abood (Eds.), Functional Diversity of Interacting Receptors, The New York Academy of Sciences, New York, 1995, pp. 218-221.
19. Levin E.D., Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology. 123:1996;88-97.
20. Levin E.D., Torry D., Christopher N.C., Yu X., Einstein G., Schwartz-Bloom R. Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? Brain Res. Bull. 43:1997;295-304.
21. London E.D., Ball M.J., Waller S.B. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's disease. Neurochem. Res. 14:1989;745-750.
22. Morrow A.L., Loy R., Creese I. Alteration of nicotinic agonist binding sites in hippocampus after fimbria transection. Brain Res. 334:1985;309-314.
23. Newhouse P.A., Potter A., Levin E.D. Nicotinic systems and Alzheimer's disease: implications for therapeutics. Drugs and Aging. 11:1997;206-228.
24. Newhouse P.A., Sunderland T., Tariot P.N., Blumhardt C.L., Weingartner H., Mellow A., Murphy D.L. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology. 95:1988;171-175.
25. 3H -acetylcholine binding sites in the frontal cortex of Alzheimer's brains Neurosci. Lett. 72:1986;115-119.
26. Ohno M., Yamamoto T., Watanabe S. Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol. Biochem. Behav. 45:1993;89-93.
27. L.J. Pellegrino, A.S. Pellegrino, A.J. Cushman, A Stereotaxic Atlas of the Rat Brain, 2nd edn., Plenum, New York, 1979.
28. B.J. Sahakian, G.M.M. Jones, The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type, in: F. Adlkofer, K. Thruau (Eds.), Effects of Nicotine on Biological Systems, Birkhauser Verlag, Basel, 1991, pp. 623-230.
29. Socci D.J., Sanberg P.R., Arendash G.W. Nicotine enhances morris water maze performance of young and aged rats. Neurobiol. Aging. 16:1995;857-860.
30. 3H ]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study Neurology. 38:1988;720-723.
31. Widzowski D.V., Cregan E., Bialobok P. Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats. Drug Dev. Res. 31:1994;24-31.
32. A.L. Wilson, J.R. Mccarten, L.K. Langley, T. Bauer, J. Monley, S. Rottunda, E. McFalls, C. Kovera, Transdermal nicotine administration in Alzheimer's disease: effects on cognition, behavior and cardiac function, in: K. Iqbal, J.A. Mortimer, B. Winblad, H.M. Wisniewski (Eds.), Research Advances in Alzheimer's Disease and Related Disorders, Wiley, Baffins Lane, Chichester, England PO19 7UD, 1995, pp. 305-314.